LONG BEACH, CA and TORONTO, May 15, 2023 /CNW/ - Glass House Brands Inc. ("Glass House" or the "Company") (NEO: GLAS.A.U) (NEO: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., today reported financial results for its first quarter ending March 31, 2023.
First Quarter 2023 Highlights
(Unless otherwise stated, all results and dollar references are in U.S. dollars)
Management Commentary
"In the first quarter of this year, we achieved free cash flow positive operations one quarter ahead of our guidance. This performance signals that we have crossed a critical threshold in our operations, one that will hopefully lead to increasingly stronger cash flow generation in the months and years ahead," stated Kyle Kazan, Co-Founder, Chairman and CEO of Glass House.
"We also exceeded our production, revenue and margin guidance for the quarter and narrowed our Adjusted EBITDA2 loss to $0.1 million versus a $2.6 million loss in Q4. Collectively, our performance in the first quarter of 2023 continues to demonstrate that our unique business model has significant competitive advantages that we are just beginning to unlock, which we expect will lead to tremendous growth in both revenues and profitability in the future along with driving substantial value for shareholders."
"We are increasingly optimistic about future pricing trends based on the latest results in our business as well as what we are seeing across the industry in California relative to capacity and licensing renewals. From June 2022 through the end of April, we estimate licensed California cultivation capacity has fallen by more than 16 million sq. ft. of canopy representing about a 21% reduction in acreage under cultivation."
"In summary, we continued to execute well against our strategic priorities in the first quarter of this year, driving significant growth and hitting several key profitability milestones including reaching positive free cash flow1. We are consistently demonstrating the durable competitive advantage of our vertically integrated model."
"I'd like to once again extend a warm invitation to all shareholders to attend Investor Sesh 2023, where investors can tour our unicorn greenhouse facility, ask questions directly to Graham and me along with the rest of our talented C-Suite, and join our annual general shareholder meeting. It will be held on Friday, June 23, at our SoCal Farm in Camarillo, CA from 9:00 AM to 4:00 PM Pacific Time. Transparency is part of our name, and our culture of transparency is reflected in our desire to personally meet and provide tours to our loyal investor base."
First Quarter 2023 Operational Highlights
Subsequent Events
Media Highlights
Q1 2023 Financial Results Discussion
Net revenues for Q1 2023 were $29.0 million, 108% growth versus Q1 2022 and a 10% sequential decline versus Q4 2022 primarily driven by seasonality. This result was at the high end of our Q1 guidance of $27 million to $29 million.
Wholesale biomass revenue of $14.5 million increased 182% versus Q1 2022 and was down 7% sequentially versus Q4 2022. In the quarter, product sold increased 179% year-on-year to over 49,923 pounds of equivalent dry weight.3 The increase in weight available for sale was driven by a 188% increase in production versus last year to approximately 48,100 pounds as a result of incremental production from the Company's SoCal farm.
Retail revenue in Q1 of $9.4 million increased 93% year-over-year but declined 12% on a sequential basis. The year-over-year increase was primarily a result of incremental revenues from four retail locations we acquired in Q3, the new Farmacy in Isla Vista that opened in mid-December and a new Farmacy in Santa Ynez that opened in the first half of January. For Q2 earnings, our retail footprint will include ten dispensaries with the opening of the NHC Turlock store in late April. Excluding the impact of the excise tax change on January 1, 2023, when retailers began collecting excise tax which resulted in lower revenue, revenue is estimated to have declined 2% sequentially.
Wholesale CPG revenues were $5.2 million, an increase of 30% compared to the prior year and a 13% decline sequentially, ahead of our guidance of down 20% sequentially. The retail credit environment continues to be very challenging, but we were able to navigate this better than anticipated. Discounting is still higher than we'd like to see but has remained relatively stable over the past six months and is significantly improved from a year ago. During Q1, discount as a percent of gross sales was 21%, up slightly from 19% in Q4 but well below the 42% we experienced in Q1 22.
Consolidated gross profit was $12.0 million, or 41% of net revenues, compared to $2.3 million, or 17%, in Q1 2022 and $10.2 million, or 32% in Q4 2022. This is the highest gross margin percent since Q2 2022 which was the last quarter before wholesale prices began their large decline. Importantly, gross margin in each of our three business lines was flat or showed improvement on both a sequential and year-over-year basis.
The sequential increase in gross margin was primarily due to a 23% sequential increase in the average wholesale biomass selling price which rose to $290 per pound. Other factors aiding gross margin improvement were a ten-percentage point increase in retail gross margins from Q4 22 and a 33 percentage point sequential increase in CPG gross margins to 18%. The improvement in retail gross margin was expected. As we mentioned in our Q4 22 earnings call, retailers have been responsible for collecting and remitting excise tax to the state since January 1st of this year. This duty previously belonged to distributors. With this change, the cost of inventory to retailers is reduced by the amount of the excise tax and as a result it is no longer included in revenue but is charged to the consumer as a tax. This does not change the total gross margin dollars collected but reduces inventory cost and revenue by the same amount and results in a higher gross margin by about 10 percentage points. The improvement in CPG gross margin was influenced by two key factors. Our fourth quarter was negatively impacted by several one-time items related to the Plus relaunch and heavy discounting related to the Allswell launch. In addition, we have fully implemented a disciplined sales and operating process that tightly links the sales and production forecast at the item level to ensure better control of inventory levels.
General and administrative expenses were $11.4 million for the quarter compared to $13.9 million in Q4 2022. The $2.5 million reduction was primarily attributable to stock compensation which decreased by $2.1 million to $1.6 million. No new grants were given in the first quarter compared to the fourth quarter, which contained several year-end adjustments. We expect this number to increase in subsequent quarters. The remainder is due to a reduction in bad debt expense. In Q4 22 we incurred bad debt expense of $0.6 million related to Plus receivables from the acquisition.
Sales and marketing expenses were $0.7 million, down 25% year-on-year and 24% sequentially as we continue to be choiceful about where we invest in marketing. Professional fees were $1.5 million, down 42% year-on-year and down 20% from Q4 2022. We have significantly reduced our reliance on outside legal and consulting resources over the last 6 months. We will continue to look for areas where we can further reduce our expenses both in professional fees and general and admin expenses. Our plan all along has been to limit growth in SG&A spending as we increased revenue to improve cash flow and profitability.
Depreciation and amortization in Q1 2022 was $3.8 million, up $0.4 million from Q4 due to the effects of capex spending in the fourth quarter of 2022 for both our SoCal Farm and the Isla Vista and Santa Ynez dispensaries.
During the quarter, the company recognized a non-cash impairment expense of $23.0M for Goodwill and Intangible Assets in its Wholesale CPG business segment related to the Plus Products Holdings acquisition. The impairment was triggered by a decline in the outlook for revenue and profit for the Wholesale CPG business segment which resulted in the fair value of the business segment being less than the carrying amount. This difference created the impairment charge in the quarter.
Adjusted EBITDA2 loss was $(0.1) million in Q1 2023, compared to adjusted EBITDA loss of $2.6 million in Q4 2022. The increase was driven by top line growth, gross margin expansion and improved management of operating expenses. Please note, the Q4 22 adjusted EBITDA2 result included the incremental manufacturing costs and inventory write offs associated with the Plus relaunch and the bad debt expense associated with the Plus distributor move in Q3 22.
We generated $4.5 million of cash from operations in Q1 23 versus cash usage from operations of $9.3 million in Q4 22 and $15.5M Q1 22. In Q1 our cash impact from net income improved to ($4.1) million from ($6.6) million in Q4. In addition, working capital benefited by $5.6 million because there was no income tax paid in the quarter. Recall in Q4 22, we paid our state and federal taxes for fiscal year 2021. In addition, we had favorable working capital broadly within the Q1 23 quarter.
Capital spending was $1.1 million in Q1 compared to $4.1 million in Q4 as the capital expenditures associated with the Isla Vista and Santa Ynez stores were complete in Q4 and the capital expenditures associated with the SoCal farm dropped to $1 million vs. $2.5 million in Q4.
2023 Outlook
The Company is providing the following guidance for 2023 based on the strength of our first quarter results and current trends from the first quarter of 2023.
2023 Cash Flow and EBITDA2
With the improved wholesale pricing which we assume maintains for the balance of the year, we expect to have positive operating cashflow and positive adjusted EBITDA in Q2 and for each quarter the rest of the year.
Q2 2023 Outlook
We expect revenue to be between $38 million and $40 million. The increase vs. Q1 23 is being driven by the seasonal increase in production of biomass due to higher sunlight levels in Q2 relative to Q1 and our assumption CPG and Retail revenue will collectively be flat relative to Q1 due to the continued difficult retail environment. Our average selling price for wholesale biomass is projected at $325 per pound based on trends through the early part of May.
We expect consolidated gross margin percent to be in the mid-40s versus Q1's 41% because of the higher seasonal production in cultivation which we project to be 75,000 pounds, leading to an expected reduction in cost of production to $150 per pound in Q2 from $196 in Q1. The $150 pound level is a 5% reduction from Q2 22, and the projection of 75,000 pounds produced is a 198% increase vs. Q2 22.
In addition, we expect adjusted EBITDA2 to exceed $5 million and expect operating cash flow to be similar to Q1 at around $4 million.
We expect capex to be similar to Q1 at approximately $1 million.
2023 Fiscal Year
We are maintaining our revenue guidance of $160 million for 2023 but are shifting sales between our segments.5 As a result of the higher pricing in biomass wholesale, we are increasing our wholesale revenue projection to $100 million from $85 million. We are raising our projected average selling price per pound to $330 from $300 and expect it to increase from Q1 through the remainder of the year as the mix of flower produced during the year increases.
We are reducing our CPG revenue guidance to $20 million from $25 million which takes into account our move to a direct distribution model to our owned stores, and results in a reduction in top line revenue as we previously sold CPG to our distributor who then sold to our stores. It also reflects the continued difficult retail landscape and our expectation that we will be dealing with significant retailer distress and high levels of account shipping holds during the year.
In addition, we are reducing our retail revenue guidance to $40 million from $50 million because of the extremely competitive marketplace, heavy discounting and our new stores not meeting internal projections.
Finally, for this fiscal year we are raising our biomass production estimate to 315,000 pounds from 310,000 pounds, but raising our cost of production3,4 estimate to $140 per pound from $130. Given the state of the wholesale biomass market, with strong demand and improving pricing, we have increased our emphasis on maximizing production, which is reflected in our increased production estimates. In parallel we are working on a number of operational improvements to processing, which we believe will have long term net benefits, but which have short term efficiency costs. Until we see those improvements translate, we are being slightly more conservative on our full year production costs. We remain confident in our long-term cost target of $100 per pound. The new guidance represents a 64% increase for production and a 2% reduction in costs vs. FY 2022. Note that we typically produce roughly 60% of the year's total biomass volume in the second half, and we expect this to hold true in FY 23. In FY 22, 78% of our biomass was produced in the second half of the year when production costs are at their lowest, biasing the annual cost of production number downwards. In the second half of 2023 we now anticipate the cost of production3,4 will be below $120 per pound versus our original projection of below $110 per pound. This is still an 8% decrease vs. the same period in 2022.
None of the above guidance includes any impact from the potential greenhouse expansion discussed earlier.
Financial results and analyses will be available on the Company's investor relations website (https://ir.glasshousegroup.com/) and SEDAR (www.sedar.com).
Unless otherwise stated, all results are in U.S. dollars.
Net Income / (Loss) | ||||
(000's) | Q1 2022 | Q4 2022 | Q1 2023 | |
Revenues, net | $ 13,972 | $ 32,189 | $ 29,022 | |
Cost of goods sold | $ 11,633 | $ 21,969 | $ 17,066 | |
Gross profit | $ 2,339 | $ 10,219 | $ 11,956 | |
% of Net Sales | 17 % | 32 % | 41 % | |
Expenses: | ||||
General and administrative | $ 9,423 | $ 13,912 | $ 11,386 | |
Sales and marketing | $ 866 | $ 859 | $ 652 | |
Professional fees | $ 2,571 | $ 1,876 | $ 1,500 | |
Depreciation and amortization | $ 2,607 | $ 3,416 | $ 3,836 | |
Impairment | $ - | $ - | $ 23,007 | |
Total expenses | $ 15,467 | $ 20,063 | $ 40,382 | |
Loss from operations | $ (13,128) | $ (9,843) | $ (28,425) | |
Total other expense | $ 8,049 | $ 5,174 | $ 7,938 | |
Provision for income taxes | $ (1,351) | $ 1,729 | $ 2,422 | |
Net income (loss) | $ (19,826) | $ (16,747) | $ (38,785) | |
Adjusted EBITDA | ||||
(000's) | Q1 2022 | Q4 2022 | Q1 2023 | |
Net income (loss) | $ (19,826) | $ (16,747) | $ (38,785) | |
Interest | $ 1,198 | $ 2,168 | $ 2,080 | |
Depreciation and amortization | $ 2,607 | $ 3,416 | $ 3,836 | |
Taxes | $ (1,351) | $ 1,729 | $ 2,422 | |
EBITDA (non-GAAP) | $ (17,371) | $ (9,433) | $ (30,447) | |
Share-based Compensation Expense | $ 2,682 | $ 3,770 | $ 1,631 | |
Stock Appreciation Rights Expense | $ 69 | $ - | $ - | |
Loss on Equity Method Investments | $ 354 | $ 709 | $ 2,264 | |
(Gain) Loss on Change in Fair Value of Derivative Liabilities | $ - | $ (48) | $ (13) | |
Impairment Expense | $ - | $ - | $ 23,007 | |
Loss on Extinguishment of Debt | $ - | $ - | $ - | |
Loss on Disposition of Subsidiary | $ - | $ - | $ - | |
Non-Operational Startup Costs | $ 893 | $ 319 | $ - | |
Change in Fair Value of Contingent Liabilities | $ 6,481 | $ 2,086 | $ 3,410 | |
Non-Operational Notes Receivable Bad Debt Reserve | $ - | $ - | $ - | |
Acquisition Related Professional Fees | $ 535 | $ - | $ - | |
Adjusted EBITDA (non-GAAP) | $ (6,358) | $ (2,597) | $ (149) | |
Select Balance Sheet Information | ||||
(000's) | Q1 2022 | Q4 2022 | Q1 2023 | |
Cash, Cash Equivalents and Restricted Cash | $ 24,833 | $ 14,144 | $ 16,368 | |
Accounts receivable, net | 2,518 | 5,653 | 3,681 | |
Prepaid expenses and other current assets | 7,610 | 8,347 | 4,627 | |
Inventory | 7,599 | 12,058 | 14,681 | |
Current portion of notes receivable | - | 1,256 | 1,301 | |
Total Current assets | $ 42,560 | $ 41,457 | $ 40,658 | |
Operating lease right-of-use assets, net | 3,016 | 10,848 | 10,562 | |
Investments | 6,943 | 4,246 | 1,982 | |
Property, plant and equipment, net | 206,107 | 216,717 | 214,473 | |
Intangible Assets, Net and Goodwill | 10,509 | 70,460 | 47,036 | |
Deferred Tax Asset | 706 | 1,290 | 1,160 | |
Other assets | 3,308 | 3,650 | 3,711 | |
Total Assets | $ 273,150 | $ 348,668 | $ 319,584 | |
Accounts payable and accrued liabilities | $ 7,319 | $ 22,334 | $ 25,852 | |
Income taxes payable | 5,481 | 7,550 | 9,412 | |
Contingent earnout liability | 44,910 | 14,657 | 18,059 | |
Shares payable | 2,757 | 8,589 | 8,596 | |
Current portion of operating lease liabilities | 286 | 1,078 | 1,123 | |
Current portion of notes payable | 39 | 40 | 48 | |
Total current liabilities | $ 60,792 | $ 54,247 | $ 63,090 | |
Operating lease liabilities, net of current portion | 2,790 | 9,859 | 9,560 | |
Other non-current liabilities | 1,540 | 4,505 | 4,877 | |
Deferred tax liabilities | - | - | - | |
Notes payable, net of current portion | 45,068 | 62,619 | 62,887 | |
Total Liabilities | $ 110,191 | $ 131,231 | $ 140,414 | |
Preferred Equity Series B and C | - | 56,534 | 58,299 | |
APIC, Accumulated Deficit and Non-Controlling Int. | 162,959 | 160,904 | 120,871 | |
Total Shareholders' Equity | 162,959 | 217,438 | 179,170 | |
Total Liabilities and Shareholders' Equity | $ 273,150 | $ 348,668 | $ 319,584 | |
Equity Table | ||||
(000's) | Q1 23 | Q4 22 | Change | Comments |
Total Equity and Exchangeable Shares | 68,376 | 68,220 | 156 | Exercise of RSU's |
Total Warrants | ||||
Series C | 1,000 | 940 | 60 | Exercise price of $5.00 with an expiration date of August 2027 |
Series B | 10,000 | 10,000 | - | Exercise price of $5.00 with an expiration date of August 2027 |
Series A | 2,654 | 2,654 | - | Exercise price of $10.00 with an expiration date of June 2024 |
SPAC | 30,665 | 30,665 | - | Exercise price of $11.50 with an expiration date of June 2026 |
Total Warrants | 44,319 | 44,259 | 60 | |
Stock Options | 1,452 | 1,453 | (1) | Exercise Price between $2.26 and $4.60 with expiration dates from October 2024 to October 2026 |
RSU's | 1,874 | 2,001 | (127) | Up to 3-year vesting through 2025 |
Total | 3,326 | 3,453 | (127) | |
Convertible Debentures | ||||
Series A | $ 11,895 | $ 11,895 | $ - | 8% semi annual interest, cash or shares, higher of 10 day VWAP 5 trading days prior to pay date or $4.08, Maturity 4/15/27 |
Series B | $ 4,111 | $ 4,111 | $ - | 8% semi annual interest, cash or shares, lower of 10 day VWAP 5 trading days prior to pay date or $10.00, Maturity 4/15/27 |
Total | $ 16,006 | $ 16,006 | $ - | |
Share Price at Quarter End | $ 2.75 | $ 1.96 | $ 0.79 | |
# of Shares if converted assuming share price at quarter end | 4,410 | 5,013 | (603) | |
Select Cash Flow Information | ||||
(000's) | Q1 2022 | Q4 2022 | Q1 2023 | |
Net Income (Loss) | $ (19,826) | $ (16,747) | $ (38,785) | |
Share-based compensation | $ 2,682 | $ 3,770 | $ 1,631 | |
Depreciation and amortization | $ 2,607 | $ 3,416 | $ 3,836 | |
Other | $ 5,201 | $ 2,929 | $ 29,246 | |
Cash From Net Income (Loss) | $ (9,335) | $ (6,632) | $ (4,071) | |
Accounts receivable | $ 295 | $ 709 | $ 2,053 | |
Prepaid expenses and other current assets | $ (2,047) | $ (757) | $ 3,720 | |
Inventory | $ (1,003) | $ 628 | $ (2,623) | |
Other assets | $ (968) | $ (182) | $ (48) | |
Accounts payable and accrued liabilities | $ (2,896) | $ (845) | $ 3,432 | |
Income taxes payable | $ 442 | $ (3,747) | $ 1,862 | |
Other | $ 33 | $ 1,505 | $ 133 | |
Working Capital Impact | $ (6,143) | $ (2,689) | $ 8,529 | |
Operating Cash Flow | $ (15,478) | $ (9,321) | $ 4,458 | |
Purchases of property and equipment | $ (12,876) | $ (4,087) | $ (1,090) | |
Other | $ (100) | $ (764) | $ (45) | |
Net Investing Activities | $ (12,977) | $ (4,852) | $ (1,135) | |
Distributions to Preferred Shareholders | $ (870) | $ (1,135) | $ (1,367) | |
Other | $ 91 | $ 11,914 | $ 269 | |
Net Financing Activities | $ (779) | $ 10,779 | $ (1,099) | |
Cash Change | $ (29,234) | $ (3,393) | $ 2,225 | |
Cash and cash equivalents, beginning of period | $ 54,067 | $ 17,536 | $ 14,144 | |
Cash and Cash, Equivalents, End of Period | $ 24,833 | $ 14,144 | $ 16,368 | |
Revenue | |||||||||
(000's $) | Q122 | Q222 | Q322 | Q422 | Q123 | FY21 | FY22 | ||
Retail (B2C) | $ 4,858 | $ 4,839 | $ 6,440 | $10,593 | $ 9,373 | $21,734 | $26,731 | ||
Wholesale CPG (B2B) | $ 3,992 | $ 4,945 | $ 7,862 | $ 5,989 | $ 5,182 | $25,543 | $22,788 | ||
Wholesale (Biomass (B2B) | $ 5,122 | $ 6,689 | $13,954 | $15,607 | $14,467 | $22,169 | $41,373 | ||
Total | $13,972 | $16,473 | $28,257 | $32,189 | $29,022 | $69,447 | $90,891 | ||
Sequential % Change | |||||||||
Retail (B2C) | -5 % | 0 % | 33 % | 64 % | -12 % | ||||
Wholesale CPG (B2B) | -41 % | 24 % | 59 % | -24 % | -13 % | ||||
Wholesale (Biomass (B2B) | -21 % | 31 % | 109 % | 12 % | -7 % | ||||
Total | -24 % | 18 % | 72 % | 14 % | -10 % | ||||
% change to LY | |||||||||
Retail (B2C) | -3 % | -24 % | 23 % | 106 % | 93 % | 50 % | 23 % | ||
Wholesale CPG (B2B) | -31 % | -19 % | 13 % | -11 % | 30 % | 93 % | -11 % | ||
Wholesale (Biomass (B2B) | 14 % | 8 % | 180 % | 140 % | 182 % | 8 % | 87 % | ||
Total | -8 % | -12 % | 65 % | 75 % | 108 % | 44 % | 31 % | ||
Gross Profit | ||||||||
(000's $) | Q122 | Q222 | Q322 | Q422 | Q123 | FY21 | FY22 | |
Retail (B2C) | $ 2,084 | $ 2,037 | $ 2,651 | $ 4,482 | $ 4,871 | $ 9,419 | $11,253 | |
Wholesale CPG (B2B) | $ 655 | $ 89 | $ 1,078 | $ (917) | $ 921 | $ 5,174 | $ 905 | |
Wholesale (Biomass (B2B) | $ (400) | $ (1,872) | $ 5,011 | $ 6,661 | $ 6,165 | $ 1,427 | $ 9,400 | |
Total | $ 2,339 | $ 254 | $ 8,726 | $10,219 | $11,956 | $16,019 | $21,538 | |
% of Revenue | ||||||||
Retail (B2C) | 43 % | 42 % | 41 % | 42 % | 52 % | 43 % | 42 % | |
Wholesale CPG (B2B) | 16 % | 2 % | 14 % | -15 % | 18 % | 20 % | 4 % | |
Wholesale (Biomass (B2B) | -8 % | -28 % | 36 % | 43 % | 43 % | 6 % | 23 % | |
Total | 17 % | 2 % | 31 % | 32 % | 41 % | 23 % | 24 % | |
Wholesale Biomass Production and Cost per Pound | |||||||||
Q122 | Q222 | Q322 | Q422 | Q123 | FY21 | FY22 | |||
Equivalent Dry Pounds of Production | 16,729 | 25,173 | 74,624 | 75,344 | 48,099 | 96,785 | 191,870 | ||
% change to LY | 7 % | 9 % | 164 % | 153 % | 188 % | 79 % | 98 % | ||
Cost per Equivalent Dry Pounds | $ 238 | $ 159 | $ 134 | $ 127 | $ 196 | # | $ 189 | $ 143 | |
of Production | |||||||||
% change to LY | -2 % | -18 % | -25 % | -24 % | -18 % | -14 % | -24 % | ||
Ending Operational Canopy (000 sq. ft) | 332 | 332 | 959 | 959 | 959 | 332 | 959 | ||
Wholesale Biomass Sold and Average Selling Price per Pound | ||||||||||||||
Q122 | Q222 | Q322 | Q422 | Q123 | FY21 | FY22 | ||||||||
Equivalent Dry Pounds Sold | 17,894 | 19,859 | 68,512 | 66,127 | 49,923 | # | 69,153 | 172,392 | ||||||
% change to LY | 41 % | 38 % | 265 % | 184 % | 179 % | 235 % | 149 % | |||||||
Equivalent Dry Pounds Sold | $ 188 | $ 237 | $ 204 | $ 236 | $ 290 | $ 233 | $ 218 | |||||||
Average Selling price | ||||||||||||||
% change to LY | -29 % | -30 % | 7 % | 29 % | 54 % | -58 % | -6 % | |||||||
Equivalent Dry Pounds Average Selling Price excludes the impact of cultivation tax. | ||||||||||||||
Conference Call
The Company will host a conference call to discuss the results on today, May 15, 2023 at 5:00 p.m. Eastern Time.
Webcast: Click here
Dial-In Number: 1-888-664-6392
Conference ID: 77602802
Replay: 1-888-390-0541
Replay Code: 602802 #
(replay available until 12:00 midnight Eastern Time Monday, May 22, 2023)
Non-GAAP Financial Measures
Glass House defines EBITDA as Net Loss (GAAP) adjusted for interest and financing costs, income taxes, depreciation, and amortization. Adjusted EBITDA is defined as EBITDA excluding share-based compensation, stock appreciation rights expense, loss (income) on equity method investments, change in fair value of derivative liabilities, change in fair value of contingent liabilities, acquisition related professional fees, and non-operational start-up costs.
EBITDA and Adjusted EBITDA are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. Such supplemental non-GAAP financial measures are not standardized financial measures under U.S. GAAP used to prepare the Company's financial statements and might not be comparable to similar financial measures disclosed by other companies and, thus, should only be considered in conjunction with the GAAP financial measures presented herein.
The Company has provided a table above that provides a reconciliation of the Company's net loss to Adjusted EBITDA for the three months ended March 31, 2023 compared to three months ended March 31, 2022 and three months ended December 31, 2022.
Footnotes and Sources:
1. | We define Free Cash Flow as net cash from operating activities minus capital expenditures. |
2. | EBITDA and Adjusted EBITDA are non-GAAP financial measures that are not defined by U.S. GAAP and may not be comparable to similar measures presented by other companies. Please see "Non-GAAP Financial Measures" herein for further information and for a reconciliation of such non-GAAP measures to the closest GAAP measure. |
3. | Includes all dry production (flower, smalls and trim) plus equivalent dry weight for wet weight and fresh frozen not converted into dry weight by the Company. |
4. | Cost per Equivalent Dry Pound of Production, is the application of a subset of Costs of Goods Sold for cannabis biomass production (including all expenses from nursery and cultivation to curing and trimming - the point at which product is ready for sales as wholesale cannabis or to be transferred to CPG) applied to the Company's metric of dry production which includes all dry production (flower, smalls and trim) plus equivalent dry weight for wet weight and fresh frozen that is not converted into dry goods by the Company. |
5. | The Company has provided guidance that 2023 revenues will reach $160 million. The statement assumes the following in revenues from each source: 1) Annualized wholesale biomass sales of $100 million; 2) Annualized retail revenues of $40 million; 3) Annualized wholesale CPG revenues of $20 million. |
About Glass House
Glass House is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. From its greenhouse cultivation operations to its manufacturing practices, from brand-building to retailing, the company's efforts are rooted in the respect for people, the environment, and the community that co-founders Kyle Kazan, Chairman and CEO, and Graham Farrar, President, instilled at the outset. Through its portfolio of brands, which includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness, Glass House is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all. For more information and company updates, please visit www.glasshousebrands.com and https://ir.glasshousebrands.com/contact/email-alerts/.
Forward Looking Statements
This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as "forward-looking statements"). Forward-looking statements reflect current expectations or beliefs regarding future events or the Company's future performance or financial results. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates", "targets" or "believes", or variations of, or the negatives of, such words and phrases or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. Forward-looking statements in this news release include, without limitation, the Company's ability: to produce increasingly stronger cash flows in the months and years ahead; to leverage its 'unique business model that has significant competitive advantages that Glass House is just beginning to unlock' to produce tremendous growth in both revenues and profitability in the future along with driving substantial value for shareholders; to produce positive operating cashflow and positive adjusted EBITDA in Q2 23 and for each quarter the rest of the year; to achieve Q2 23 revenue between $38 million to $40 million; to achieve an average selling price for wholesale biomass of $325 per pound in Q2 23; to deliver a Q2 23 consolidated gross margin percentage in the mid-40s; to produce 75,000 pounds of wholesale biomass in Q2 23, leading to an expected reduction in cost of production to $150 per pound, also in Q2 23; to deliver adjusted EBITDA in excess $5 million and operating cash flow at around $4 million in Q2 23; to produce 2023 revenues reaching $160 million, with the following revenues from each source: 1) Annualized wholesale biomass sales of $100 million, 2) Annualized retail revenues of $40 million, 3) Annualized wholesale CPG revenues of $20 million; to achieve an average selling price per pound for wholesale biomass of $330 in 2023; to produce 315,000 pounds of biomass in 2023 at a cost per pound of $140; to achieve a cost per pound below $120 in the second half of 2023; All forward-looking statements, including those herein are qualified by this cautionary statement.
Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including financial and operational results not proving to be as expected or on the timelines expected; the Company not completing certain proposed acquisition or financing transactions at all, or on the timelines expected; the Company not achieving the synergies expected; and other risks disclosed in the Company's Annual Information Form and other public filings on SEDAR at www.sedar.com Accordingly, readers should not place undue reliance on forward-looking statements.
For more information on the Company, investors are encouraged to review the Company's public filings on SEDAR at www.sedar.com. The forward-looking statements and financial outlooks contained in this news release speak only as of the date of this news release or as of the date or dates specified in such statements. The Company disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law.
| Last Trade: | US$6.99 |
| Daily Change: | -0.06 -0.85 |
| Daily Volume: | 3,000 |
| Market Cap: | US$481.890M |
May 20, 2024 | |
Leveraging its vertically-integrated approach from mine to material manufacturing, Graphite One intends to produce high-grade anode material for the lithium-ion electric vehicle battery market and energy storage systems...
CLICK TO LEARN MORE
Northstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...
CLICK TO LEARN MORE
